{"id":2426,"date":"2018-11-19T11:25:08","date_gmt":"2018-11-19T11:25:08","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/"},"modified":"2018-11-19T11:25:08","modified_gmt":"2018-11-19T11:25:08","slug":"discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma","status":"publish","type":"journal-paper","link":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/","title":{"rendered":"Narrow Spectrum Kinase Inhibitors: Treating COPD and Steroid-Resistant Asthma"},"content":{"rendered":"<p>Stuart T. Onions, Kazuhiro Ito, Catherine E. Charron, Richard J. Brown, Marie Colucci, Fritz Frickel, George Hardy, Kevin Joly, John King-Underwood, Yasuo Kizawa, Ian Knowles, P. John Murray, Andrew Novak, Anjna Rani, Garth Rapeport, Alun Smith, Peter Strong, David M. Taddei, and Jonathan G. Williams<\/p>\n<p><strong>Abstract<\/strong><\/p>\n<p>The discovery of a novel series of therapeutic agents that has been designed and optimized for treating chronic obstructive pulmonary disease is reported. The pharmacological strategy was based on the identification of compounds that inhibit a defined subset of kinase enzymes modulating inflammatory processes that would be effective against steroid refractory disease and exhibit a sustained duration of action after inhaled delivery.<\/p>\n<p><strong>Ref:<\/strong> J. Med. Chem., 59, (5), 1727 &#8211; 1746<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Experience therapeutic potential with narrow spectrum kinase inhibitors for COPD and steroid-resistant asthma.<\/p>\n","protected":false},"featured_media":0,"template":"","category":[1],"resource_tag":[],"class_list":["post-2426","journal-paper","type-journal-paper","status-publish","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Narrow Spectrum Kinase Inhibitors for COPD and Asthma<\/title>\n<meta name=\"description\" content=\"In J. Med. Chem.: a novel compound series inhibiting a defined subset of inflammatory kinases for sustained, inhaled treatment of COPD &amp; steroid-refractory disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Narrow Spectrum Kinase Inhibitors for COPD and Asthma\" \/>\n<meta property=\"og:description\" content=\"In J. Med. Chem.: a novel compound series inhibiting a defined subset of inflammatory kinases for sustained, inhaled treatment of COPD &amp; steroid-refractory disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/sygnature-hit-to-lead-team-collaboration-scaled.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/journal-paper\\\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/journal-paper\\\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\\\/\",\"name\":\"Narrow Spectrum Kinase Inhibitors for COPD and Asthma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"datePublished\":\"2018-11-19T11:25:08+00:00\",\"description\":\"In J. Med. Chem.: a novel compound series inhibiting a defined subset of inflammatory kinases for sustained, inhaled treatment of COPD & steroid-refractory disease.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/journal-paper\\\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/journal-paper\\\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/journal-paper\\\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Narrow Spectrum Kinase Inhibitors: Treating COPD and Steroid-Resistant Asthma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"alternateName\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.youtube.com\\\/@sygnature.discovery\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/sygnature-discovery\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Narrow Spectrum Kinase Inhibitors for COPD and Asthma","description":"In J. Med. Chem.: a novel compound series inhibiting a defined subset of inflammatory kinases for sustained, inhaled treatment of COPD & steroid-refractory disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/","og_locale":"fr_CA","og_type":"article","og_title":"Narrow Spectrum Kinase Inhibitors for COPD and Asthma","og_description":"In J. Med. Chem.: a novel compound series inhibiting a defined subset of inflammatory kinases for sustained, inhaled treatment of COPD & steroid-refractory disease.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/","og_site_name":"Sygnature","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/sygnature-hit-to-lead-team-collaboration-scaled.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/","name":"Narrow Spectrum Kinase Inhibitors for COPD and Asthma","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"datePublished":"2018-11-19T11:25:08+00:00","description":"In J. Med. Chem.: a novel compound series inhibiting a defined subset of inflammatory kinases for sustained, inhaled treatment of COPD & steroid-refractory disease.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Narrow Spectrum Kinase Inhibitors: Treating COPD and Steroid-Resistant Asthma"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","alternateName":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.youtube.com\/@sygnature.discovery","https:\/\/www.linkedin.com\/company\/sygnature-discovery\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/journal-paper\/2426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/journal-paper"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/journal-paper"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/journal-paper\/2426\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=2426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=2426"},{"taxonomy":"resource_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/resource_tag?post=2426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}